Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Stimulant Selective Severity Assessment

Submitted by administrator -
Abbreviation
SSSA
Description
Stimulant Selective Severity Assessment (SSSA; adapted from Kampman et al, 1998). The SSSA is an 18-item clinician-rated instrument assessing the signs and symptoms of stimulant (cocaine, methamphetamine and other stimulants) abstinence. It is derived from the Cocaine Selective Severity Assessment, which contains items that are most frequently associated with early cocaine abstinence. The items are rated on a scale from 0-7 (with higher scores indicating greater intensity or frequency) with a maximum possible score of 112. The CSSA, from which the SSSA is adapted, has been shown to have good inter-rater reliability (correlation coefficient = 0.92, p
Studies Using This Assessment